NEOPLASM PROGRESSION

This adverse event was reported 21252 times

These drugs are most commonly taken by patients reporting NEOPLASM PROGRESSION:

# Drug Count
0 PALBOCICLIB 6070
1 SUNITINIB MALATE 1702
2 LETROZOLE 1596
3 LETROZOLE TABLETS 1334
4 FULVESTRANT 1325
5 EVEROLIMUS 869
6 CRIZOTINIB 796
7 DEXAMETHASONE 769
8 BEVACIZUMAB 747
9 CAPECITABINE 736
See all common drugs associated with NEOPLASM PROGRESSION

NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LORLATINIB 210 0.1535
1 TALAZOPARIB 81 0.1514
2 PALBOCICLIB 6070 0.1107
3 DACOMITINIB 26 0.1102
4 BEVACIZUMAB-BVZR 8 0.1053
5 CRIZOTINIB 796 0.0814
6 INOTUZUMAB OZOGAMICIN 101 0.0786
7 FULVESTRANT 1325 0.0783
8 GLASDEGIB 21 0.0669
9 RIPRETINIB 40 0.0650
See all drugs enriched for association with NEOPLASM PROGRESSION